)
Edge8 Aug 2025
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces.
Hims & Hers Health
Hims & Hers Health (HIMS) investor relations material
Hims & Hers Health AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary11 Jun, 2026
Opening remarks and agenda
CEO welcomed attendees, including directors, officers, employees, auditors, and counsel, and outlined the virtual meeting format and agenda.
Formal matters included voting on director elections, auditor ratification, and executive compensation, followed by a Q&A session.
Corporate governance
Notice of the meeting, proxy statement, and proxy card were mailed to all stockholders of record, with affidavits and oaths filed with meeting minutes.
Quorum was confirmed, allowing the meeting to transact business.
Voting rights were specified: Class A common stockholders have one vote per share, Class V common stockholders have 175 votes per share.
Board and executive committee updates
Nine directors were nominated and elected for a one-year term or until successors are elected.
Directors elected: Andrew Dudum, Deb Autor, Dr. Delos Cosgrove, Anja Manuel, Christopher Payne, Andrea Perez, Kåre Schultz, David Wells, and Kofi Amoo-Gottfried.
Analyze Class V voting power per share
Explain rationale for virtual meeting format
Explain the policy for answering Q&A submissions
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Hims & Hers Health
- 2024 revenue up 69% to $1.5B, net income $126M, 2025 guidance set at $2.3–$2.4B revenue.HIMS
Q4 20248 Jul 2026 - Q2 revenue up 52% to $315.6M, net income $13.3M, 1.9M subscribers, and raised full-year guidance.HIMSQ2 20248 Jul 2026
- 2025 revenue up 59% to $2.35B, with strong subscriber and specialty growth, and robust 2026 outlook.HIMSQ4 20258 Jul 2026
- Q1 2026 revenue rose 4% to $608M, but net loss widened on restructuring and margin pressure.HIMSQ1 20268 Jul 2026
- 2030 targets hinge on global expansion, specialty growth, and AI-driven platform leadership.HIMS2026 Evercore Global TMT Conference2 Jun 2026
- Rapidly scaling personalized health platform targets $6.5B+ revenue by 2030.HIMSInvestor presentation29 May 2026
- Proxy covers director elections, auditor ratification, and executive pay, highlighting strong growth and governance.HIMSProxy filing28 Apr 2026
- Votes sought for nine directors, auditor ratification, and executive pay at June 2026 meeting.HIMSProxy filing28 Apr 2026
- Personalized care, tech-driven growth, and global expansion fuel strong revenue and margin outlook.HIMSMorgan Stanley Technology, Media & Telecom Conference 20262 Mar 2026
Next Hims & Hers Health earnings date
Q2 202610 Aug, 2026
Hims & Hers Health
Next Hims & Hers Health earnings date
Q2 202610 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company research30 Jun 2025
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
)
Company research5 Dec 2024
Hims & Hers: Bridging Gaps in Telehealth
Hims & Hers was founded in 2016 by Andrew Dudum and has grown into a ~$4 billion company in the telehealth industry in less than a decade.
Frequently asked questions
Explore our global coverage